Point-of-Care Molecular Diagnostics Market to Grow at a CAGR of 13.4% to reach US$ 45,381.18 million from 2021 to 2028 | COVID-19 Impact and Global Analysis By The Insight Partners

“Point-of-Care Molecular Diagnostics Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.

For Sample Report Click: https://www.theinsightpartners.com/sample/TIPRE00003144/?utm_source=OpenPR&utm_medium=10225

The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.

The growth of the market is attributed to the growing demand for specific viral detection methods that consume less time for timely infection control and rising incidence of infectious diseases. However, the pricing pressures owing to reimbursement cuts restrain the Point-of-Care Molecular Diagnostics market growth. Point-of-care molecular diagnostics comprises portable devices and assays & kits to detect and diagnose diseases from human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing, due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes. Owing to these advantages, it can be applied for diagnosis in low-resource or remote areas.

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Biotechnology, medical devices, pharma Industry, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall Point-of-Care Molecular Diagnostics market globally. This report on ‘Point-of-Care Molecular Diagnostics market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcase market trends and forecast to 2028, factoring the impact of Covid -19 Situation.

ASSESING THE COVID-19 IMPACT on Point-of-Care Molecular Diagnostics Market? Visit Here for PDF Copy >> https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00003144/?utm_source=OpenPR&utm_medium=10225

MARKET SEGMENTATION

by Product & Services

Assays and Kits
Instruments
Services and Software

by Technology

PCR
Isothermal Nucleic Acid Amplification Technology (INAAT)
Other Technologies

by Application

Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other Applications

by End User

Hospitals and Clinics
Diagnostic Laboratories
Research and Academic Institutes
Others

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting Point-of-Care Molecular Diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Companies Mentioned:

bioMérieux SA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Enzo Biochem, Inc.
Abbott
binx health, Inc.
Meridian BioScience, Inc
Biocartis
Quidel Corporation
Bio-Rad Laboratories, Inc.

Key Elements that the report acknowledges:

Market size and growth rate during forecast period.
Key factors driving the “Point-of-Care Molecular Diagnostics market” market.

Key market trends cracking up the growth of the “Point-of-Care Molecular Diagnostics market” market.

Challenges to market growth.

Key vendors of “Point-of-Care Molecular Diagnostics market” market.
Detailed SWOT analysis.

Opportunities and threats faces by the existing vendors in Global “POINT-OF-CARE MOLECULAR DIAGNOSTICS” market.

Trending factors influencing the market in the geographical regions.

Strategic initiatives focusing the leading vendors.
PEST analysis of the market in the five major regions.

Buy Complete Report at: https://www.theinsightpartners.com/buy/TIPRE00003144/?utm_source=OpenPR&utm_medium=10225

Contact US
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.